Artelo Biosciences gets Japan notice of allowance for ART27.13 formulation patents
Artelo Biosciences (ARTL) secures a notice of allowance in Japan covering patent claims for the intended commercial formulation of ART27.13.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.